News & Events zu Definitive Healthcare Corp (DH)DHDefinitive Healthcare Corp

Definitive Healthcare Reports Q3 Revenue of $54.65M

Reports Q3 revenue $54.65M, consensus $54.58M. "Since joining Definitive, I've been focused on listening to our customers and our employees," said Clay Ritchey, CEO of Definitive Healthcare. "What I've heard confirms my belief in the strength of our position in the market, and it has also shown me where we can execute better. This quarter's results demonstrate the underlying health of the business and a solid foundation to build upon."

Definitive Healthcare Expands Leadership Team with New CPO and SVP of AI and Data

Definitive Healthcare announced the expansion of its leadership team, adding Rebecca Marani as Chief Product Officer and Srinivas Attipalli as SVP, Head of AI and Data. Marani joined Definitive Healthcare in 2024 and has played a key role in advancing the organization's AI-powered intelligence platform and broader portfolio AI capabilities. Most recently serving as senior vice president and head of product, she has been instrumental in shaping product strategy and guiding innovation from development through commercialization, adoption, and scale. She will continue to lead these efforts as the company brings its new AI platform to market and extends its AI roadmap to additional capabilities, including digital activation. Attipalli brings two decades of experience leading large-scale data transformation, business intelligence, and AI initiatives across Fortune 500 organizations and high-growth technology companies. He's responsible for advancing Definitive Healthcare's AI and data strategy, ensuring customers can realize the full value of the company's intelligence.

Definitive Healthcare Receives Acquisition Interest from Advent International

The special committee of the board of directors of Definitive Healthcare announced that it has received a non-binding indication of interest from Advent International on behalf of certain of its managed funds, to acquire all of the outstanding shares of the company's Class A common stock and all of the outstanding limited liability company interests of AIDH TopCo, in each case, that are not already owned by Advent or Jason Krantz, the company's founder and executive chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit.